LESLIE KATHMAN: Open Payments
NPI 1710657374 · HASTINGS, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,437 in 55 payments from 28 companies in 2025. Trend: 2023 $1,562 · 2024 $1,742 · 2025 $1,437
Food & beverage: $1,437
| Company | Payments | Amount |
|---|---|---|
| Pharmacosmos Therapeutics Inc. | 2 | $224 |
| ABBVIE INC. | 7 | $208 |
| RECORDATI_RARE_DISEASES_INC. | 2 | $109 |
| Novartis Pharmaceuticals Corporation | 4 | $89 |
| Daiichi Sankyo Inc. | 4 | $87 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $74 |
| Janssen Biotech, Inc. | 3 | $70 |
| Merck Sharp & Dohme LLC | 3 | $68 |
| Gilead Sciences, Inc. | 3 | $53 |
| Genentech USA, Inc. | 2 | $40 |
Products named: MONOFERRIC, ENJAYMO, Enhertu, KEYTRUDA, Trodelvy, FRUZAQLA, PLUVICTO, LIBTAYO.
Industry payments across NE — which companies pay providers there.
